Pricing Log in Create free account

Aardvark Therapeutics, Inc. (AARD) vs BeyondSpring Inc. (BYSI)

Aardvark Therapeutics, Inc. and BeyondSpring Inc. are both Biotechnology companies. Aardvark Therapeutics, Inc. and BeyondSpring Inc. are of similar size ($26.0M and $24.3M). Across the 8 metrics below, BeyondSpring Inc. leads on 7 and Aardvark Therapeutics, Inc. on 1.

Valuation

Metric AARD BYSI Biotechnology median
P/E n/m n/m 10.60
P/S n/m 18.57 9.40
P/B 0.34 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.65 n/m 0.66
EV/Sales n/m 15.37 9.02
Earnings yield (274.36%) (28.28%) (32.88%)
Free cash flow yield (271.94%) (66.96%) (23.13%)

Profitability

Metric AARD BYSI Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (66.02%) 24.96% (51.96%)
Return on assets (61.06%) (29.29%) (46.06%)
Return on invested capital (4,986.18%) 0.00% 0.00%

Growth

Metric AARD BYSI Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 43.11% 92.86% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AARD BYSI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.63 0.70 4.97
Net debt to EBITDA 1.72 1.42 1.01

Dividend

Metric AARD BYSI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AARD BYSI Biotechnology median
Market cap 24.29m 26.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack